Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

KPT-185 is an inhibitor of Exportin 1 (XPO1/CRM1) with anticancer activity.1,2 It reduces proliferation in a panel of patient-derived acute myeloid leukemia cells (IC50s = 100-500 nM).1 KPT-185 induces cell cycle arrest in the G1 phase and apoptosis in MOLT-4 T cell acute lymphoblastic leukemia cells and in a panel of six non-small cell lung cancer (NSCLC) cell lines in a time- and dose-dependent manner.2,3
WARNING This product is not for human or veterinary use.
1. Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia. Blood 120(9), 1765-1773 (2012).
2. KPT-
3. Antitumor effects of a novel chromosome region maintenance 1 (CRM1) inhibitor on non-